J. Goldman & CO LP Madrigal Pharmaceuticals, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $2.77 Million - $3.68 Million	11,971 New	11,971 $2.9 Million
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $459,818 - $1.42 Million	-4,528 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $422,688 - $674,853	4,528 New	4,528 $529,000

335

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.75B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.